Avid Bioservices to Participate at INTERPHEX 2018
April 09 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality development and
manufacturing services to biotechnology and pharmaceutical
companies, today announced that the company will participate in the
International Pharmaceutical Expo (INTERPHEX) 2018. The
company’s activities will include participation in a conference
panel focused on biologics outsourcing, as well as delivering a
presentation on single-use manufacturing of
biopharmaceuticals. INTERPHEX 2018 is being held April 17-19,
2018 at the Javits Center in New York, NY.
Details of Avid’s activities at INTERPHEX 2018
are as follows:
- Roger Lias, Ph.D., Avid’s president and chief executive
officer, will participate on a conference panel titled, “Biologics
Outsourcing.” The panel will take place from 2:15 – 3:00 p.m.
Eastern on Wednesday, April 18th at booth #1053 within the CMO
Theatre. The CMO Theatre is part of the conference’s
dedicated CMO/CDMO Pavilion, which is being hosted by the Pharma
and Biopharma Outsourcing Association (PBOA).
- Sun Ra Bullins, director of manufacturing at Avid, will make a
presentation titled, “The Perks and Pitfalls of a Single-Use
Biopharmaceutical Facility.” The presentation will take place
from 11:30 a.m. – 12:15 p.m. Eastern on Tuesday, April 17th at
booth #1053 within the CMO Theatre.
Sponsored by the Parenteral Drug Association
(PDA), INTERPHEX brings over 11,000 global industry professionals
and more than 630 industry leading suppliers together to “Learn it,
Experience it, Procure it” through a unique combination of no cost
technical conference, exhibits, demonstrations, roundtables,
partnering opportunities and networking to leverage quality,
efficiency and cost effectiveness in today’s ever-changing global
market. For additional details on INTERPHEX 2018, please
visit: http://www.interphex.com/.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive
range of process development, high quality cGMP clinical and
commercial manufacturing services for the biotechnology and
biopharmaceutical industries. With 25 years of experience
producing monoclonal antibodies and recombinant proteins in batch,
fed-batch and perfusion modes, Avid's services include cGMP
clinical and commercial product manufacturing, purification, bulk
packaging, stability testing and regulatory strategy, submission
and support. The company also provides a variety of process
development activities, including cell line development and
optimization, cell culture and feed optimization, analytical
methods development and product characterization.
www.avidbio.com
Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc.
(800) 987-8256
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024